RCAP
INSM icon

Resolute Capital Asset Partners’s Insmed INSM Stock Holding History

Resolute Capital Asset Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-27,301
Closed -$2.75M – 56
2025
Q2 		$2.75M Buy
+27,301
New +$2.09M 1.44% 26

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Resolute Capital Asset Partners's INSM Position: Q3 2025 in Review

Resolute Capital Asset Partners sold out of Insmed (INSM) in Q3 2025, closing a stake of 27,301 shares — an estimated $2.75M sold.

Resolute Capital Asset Partners first reported a position in INSM in Q2 2025 and held it in 1 quarter. The position peaked at $2.75M in Q2 2025. 566 funds tracked by Wall St. Rank hold INSM as of Q3 2025.

  • Resolute Capital Asset Partners reported no remaining Insmed position as of Q3 2025 after selling out during the quarter.
  • Resolute Capital Asset Partners sold 27,301 Insmed shares in Q3 2025, an estimated $2.75M.
  • Resolute Capital Asset Partners first reported a position in Insmed in Q2 2025 and held it in 1 quarter.
  • Resolute Capital Asset Partners's Insmed position peaked at $2.75M in Q2 2025.
  • 566 funds tracked by Wall St. Rank held Insmed as of Q3 2025.

Based on Resolute Capital Asset Partners's 13F filing for Q3 2025, filed 14 Nov 2025.